2021 GI Outlook (GO) Conference | November 2021-Evaluating Private Equity - What must you know before, during and after

Evaluating Private Equity - What must you know before, during and after

Video Transcription

Video Summary

In this video, Praveen Suthram discusses the topic of evaluating private equity in the context of gastroenterology. He introduces himself as an entrepreneur and healthcare futurist who has co-founded Next Services and Noble Liver. Suthram highlights the increasing momentum of private equity in gastroenterology, with over 30 transactions already taking place. He explains the business model of private equity funds, which involves taking money from limited partners and investing it in companies. Suthram emphasizes the importance of understanding EBITDA, a measure of profitability used in valuations. He also discusses the risks associated with private equity, such as the business model risk, market and debt risk, clinical autonomy risk, and ROI pressure. Suthram concludes by urging the audience to lead and reimagine gastroenterology care, taking advantage of the opportunities presented by industry changes.

Asset Subtitle

Praveen Suthrum, MBA

Keywords

Praveen Suthram

private equity

gastroenterology

evaluating

EBITDA

risks